Somnomed Limited Stock: price and insider trades · Australia
Somnomed Limited: what insiders have been doing
Every trade that managers of Somnomed Limited disclose to ASX is tracked on this page. From 18 October 2025 to 18 October 2026, the disclosure feed for Somnomed Limited logged 8 filings by 6 insiders.
No insider bought on the market over the period, while 3 insiders filed 4 sales. No amount is published for 4 filings, which the totals therefore leave out.
Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.
For context, the typical company on the same exchange (median of 1,605 companies) published 4 filings over the same period, against 8 filings here. Looking back to 2026, when coverage begins, insiders filed no purchases and 4 sales.
Source: insider filings from ASX. Past trades are no guide to future returns.
Who traded when
BuySaleTransparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended June 2026 · cache
- ShareASXASX:2924-03140808-2A1699916
- 185,000 sharesShareASXASX:2924-03128570-2A1693406
- 185,000 sharesShareASXASX:2924-03128569-2A1693404
- ▼Executives0ASX
- ▼Executives0ASX
- ShareASXISIN AU000000SOM1ASX:2924-03114593-2A1686155
- 0ShareASXISIN AU000000SOM1ASX:2924-03114033-2A1685800
- ShareASXASX:2924-03101619-2A1678093
8 of 8 declarations
About Somnomed Limited
Somnomed Limited is a company focused on developing medical devices for the treatment of sleep disorders, particularly sleep apnea. It is listed on the XASX market.